Last updated: July 09, 2026

Application No. 18/851,590

Untitled Application

Unknown

Filed

1600

Priority

Apr 29, 2022 — GB 2206348.1 +1 more

Examiner

CHOWDHURY, IQBAL HOSSAIN

Art Unit

1653

Tech Center

IPSEN BIOPHARM LIMITED

Assignee

Ipsen Biopharm Limited

OA Round

1 (Non-Final)

Interview Optional

— +58.0% interview lift. Examiner has a relatively high allowance rate (74%); +58.0% interview lift. A written response may suffice.

Based on 997 resolved cases, 2023–2026

Examiner Intelligence

CHOWDHURY, IQBAL HOSSAIN View full profile →

Grants 74% — above average

Career Allowance Rate

734 granted / 997 resolved

+13.6% vs TC avg

Strong +58% interview lift

Without

With

+58.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 12m

Avg Prosecution

42 currently pending

Career history

1026

Total Applications

across all art units

Statute-Specific Performance

§101

0.9%

-39.1% vs TC avg

§103

53.1%

+13.1% vs TC avg

§102

19.4%

-20.6% vs TC avg

§112

9.0%

-31.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 997 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/426,136

Patent 12674197

PROCESS FOR PRODUCING A CHROMATIN CONFORMATION CAPTURE (3C) LIBRARY

4y 11m to grant Granted Jul 07, 2026

18/346,715

Patent 12668820

MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO

2y 12m to grant Granted Jun 30, 2026

17/995,360

Patent 12662687

METHODS AND COMPOSITIONS FOR THE PRODUCTION OF XYLITOL FROM XYLOSE UTILIZING DYNAMIC METABOLIC CONTROL

3y 8m to grant Granted Jun 23, 2026

17/850,103

Patent 12655410

STABLE PROTEASE VARIANTS

3y 11m to grant Granted Jun 16, 2026

18/012,666

Patent 12655401

PROTEIN CONSTRUCTS OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE (MMLV-RT)

3y 5m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

74%

Grant Probability

99%

With Interview (+58.0%)

2y 12m

Median Time to Grant

Low

PTA Risk

Based on 997 resolved cases by this examiner. Grant probability derived from career allowance rate.